Journal of Drug Metabolism & Toxicology

Journal of Drug Metabolism & Toxicology
Open Access

ISSN: 2157-7609

Journal of Drug Metabolism & Toxicology : Citations & Metrics Report

Articles published in Journal of Drug Metabolism & Toxicology have been cited by esteemed scholars and scientists all around the world. Journal of Drug Metabolism & Toxicology has got h-index 20, which means every article in Journal of Drug Metabolism & Toxicology has got 20 average citations.

Following are the list of articles that have cited the articles published in Journal of Drug Metabolism & Toxicology.

  2021 2020 2019 2018 2017 2016

Year wise published articles

29 18 4 11 12 41

Year wise citations received

240 227 190 190 157 269
Journal total citations count 1597
Journal impact factor 14.27
Journal 5 years impact factor 11.69
Journal cite score 16.36
Journal h-index 20
Journal h-index since 2017 16
Important citations

In vitro and in vivo comparison of gemcitabine and the gemcitabine analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) cytosine (fac) in human orthotopic and genetically modified mouse pancreatic cancer models

Hippo pathway mediates resistance to cytotoxic drugs

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer.

Critical regulation of calcium signaling and nmda-type glutamate receptor in developmental neural toxicity

Effects of silver nanoparticles on human and rat embryonic neural stem cells

review on non-clinical studies

Using domestic and free-ranging arctic canid models for environmental molecular toxicology research

effects of azole fungicide on amphibian: review

Inhibitory effect of jengkol leaf (pithecellobium jiringa) extract to inhibit candida albicans biofilm

Safety assessment of drug metabolites:? characterization of chemically stable metabolites

Plasma-pooling methods to increase throughput for in vivo pharmacokinetic screening

Metabolites and safety: what are the concerns, and how should we address them?

Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative nmr: addressing metabolites in safety testing (mist) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.

Seeing through the mist: abundance versus percentage. commentary on metabolites in safety testing.

metabolites in safety testing (mist): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.

Which human metabolites have we mist? retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development.

a simple model predicts ugt-mediated metabolism.

Metabolic syndromes in endocrine system

Metabolomics: the future of systems biology

drug resistance and the prevention strategies in food borne bacteria: an update review.

Relevant Topics